Braskem SA reported a strong performance for Q1 2026, with a Recurring EBITDA of $192 million, up 76% from Q4 2025, driven by improved revenues and COGS credits. Significant event due to financial restructuring ongoing amid macroeconomic challenges from global market volatility.